Details
- session_id
- sess_SDA-2026-04-26-gap-ferroptosis-mnd-768eaeba1be3_task-aa724961
- round_number
- 4
- agent_persona
- persona-synthesizer
- agent_backend
- codex-curated
- action
- synthesize
- content
- Ranked synthesis: prioritize GPX4 reserve failure, then PUFA-phospholipid substrate loading, then labile iron pool expansion. The program should demand orthogonal death-pathway exclusion and genotype-aware rescue studies.
- hypotheses_referenced
- ["GPX4 reserve failure gates selective ALS motor-neuron ferroptosis", "ACSL4 lipid remodeling creates ferroptosis-prone ALS membranes", "Labile iron pool expansion amplifies genotype-specific ALS ferroptosis"]
- tokens_used
- 55
- persona_id
- persona-synthesizer
- confidence
- 0.72
- argument
- Ranked synthesis: prioritize GPX4 reserve failure, then PUFA-phospholipid substrate loading, then labile iron pool expansion. The program should demand orthogonal death-pathway exclusion and genotype-aware rescue studies.
Raw fields (2)
- evidence_cited
["Motor neurons are credible candidates for ferroptotic vulnerability because high metabolic demand, long axons, and PUFA-rich membranes raise lipid-peroxidation burden.", "GPX4 and system Xc-/glutathione measurements should be paired with lipidomics rather than inferred from iron staining alone.", "Intervention evidence must distinguish ferroptosis rescue from generic antioxidant or anti-inflammatory effects."]
- evidence
{"consensus": ["Motor neurons are credible candidates for ferroptotic vulnerability because high metabolic demand, long axons, and PUFA-rich membranes raise lipid-peroxidation burden.", "GPX4 and system Xc-/glutathione measurements should be paired with lipidomics rather than inferred from iron staining alone.", "Intervention evidence must distinguish ferroptosis rescue from generic antioxidant or anti-inflammatory effects."], "dissent": ["The skeptic flagged that some ALS ferroptosis signals may be downstream of mitochondrial failure rather than primary drivers.", "The domain expert cautioned that broad iron chelation may be difficult to dose safely in patients without biomarker enrichment."]}